[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.94.5. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 423
Citations 0
Invited Commentary
June 2016

Evaluating Appropriate Blood Transfusion in Cancer Surgery

Author Affiliations
  • 1Surgical Outcomes and Quality Improvement Center, Feinberg School of Medicine, Department of Surgery, Northwestern University, Chicago, Illinois
JAMA Surg. 2016;151(6):525-526. doi:10.1001/jamasurg.2015.5104

The desire to limit blood use in oncologic surgery originated with the finding of increased immunosuppression in patients who received transfusions while undergoing a renal transplant.1 Subsequently, an association was demonstrated between transfusion and increased rates of cancer recurrence and worse overall oncologic prognosis,2 with the results being most pronounced for transabdominal oncologic procedures.3,4

First Page Preview View Large
First page PDF preview
First page PDF preview
×